Low pressure hyperbaric therapy shown effective in helping metabolic syndrome and reducing cardiac risks
Posted on Monday, May 8th, 2017
A new study in the Journal of atherosclerosis and thrombosis published this year shows that low pressure hyperbaric oxygen therapy can be a very effective tool for helping those suffering from metabolic syndrome.
Metabolic syndrome is a cluster of conditions — increased blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol or triglyceride levels — that occur together, increasing your risk of heart disease, stroke and diabetes.
This study looked at only 1.25 ATA (low pressure hyperbarics) and found that this dosage was effective enough to produce a lowering of blood sugars, blood pressure, total cholesterol, and insulin. Many other positive benefits were noted, click here to read the study in full.
About the Author
Dr. Zayd Ratansi, ND
Dr. Zayd Ratansi is a licensed Naturopathic Physician with advanced certifications in hyperbaric medicine, bio-oxidative medicine, low level light therapy, chelation therapy and environmental medicine. He specializes in the treatment of brain injuries and other neurological conditions using hyperbaric oxygen therapy.
Dr. Ratansi has worked with hyperbaric therapy for over 18 years and is widely regarded as a world authority on hyperbaric therapy, and more recently targeted hyperbaric therapy. He lectures worldwide on the use of hyperbaric oxygen therapy for neurological conditions and has played a leading role in implementing protocols on the use of hyperbaric therapy in the mainstream medical setting.
His passion is to share scientific information on hyperbaric therapy to give the public greater empowerment to make their own choices on whether or not hyperbaric therapy would be appropriate for them, while also helping to facilitate the safest access to hyperbaric therapy to gain the most therapeutic benefit.